Inventor · disambiguated record
Michael Tacke
Also filed as: TACKE MICHAEL · TACKE MICHAEL D
14 granted patents·25 pending applications·37 citations·filing 1997–2021
87Inventor score
Files withROCHE DIAGNOSTICS OPERATIONS13ROCHE DIAGNOSTICS OPERATIONS INC5WILD NORBERT4TACKE MICHAEL3ANDRES HERBERT2
Top patents by PatentIndex Score
39 records- 0190US9687890B2Fluid collection system and related methodsINDEPENDENCE ENTPR INC·Filed 2014·Granted Jun 27, 2017·17 cites·13 claims
- 0275US9518990B2Secernin-1 as a marker for cancerWILD NORBERT·Filed 2011·Granted Dec 13, 2016·4 cites·4 claims
- 0375US8741587B2ARMET as a marker for cancerROESSLER MARKUS·Filed 2011·Granted Jun 3, 2014·3 cites·9 claims
- 0466US8980573B2Method for providing diagnosis of cancer using seprase as a markerROLLINGER WOLFGANG·Filed 2010·Granted Mar 17, 2015·2 cites·15 claims
- 0564US11618790B2Polypeptide-polynucleotide-complex and its use in targeted effector moiety deliveryHOFFMANN LA ROCHE·Filed 2019·Granted Apr 4, 2023·0 cites·11 claims
- 0660US7205118B2Nicotinamide N-methyltransferase as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2005·Granted Apr 17, 2007·1 cites·3 claims
- 0760US2015072355A1Flap endonuclease-1 as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 0859US10982007B2Detection of a posttranslationally modified polypeptide by a bivalent binding agentROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Granted Apr 20, 2021·0 cites·3 claims
- 0957US6020195AAntibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agentROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Feb 1, 2000·10 cites·6 claims
- 1057US2014219998A1Armet as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 1156US2016169895A1Flap endonuclease-1 as a marker for cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2016·Application pending·0 cites
- 1256US2015192587A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 1356US2016377625A1Armet as a marker for cancerROCHE DIAGNOSTICS OPERATIONS INC·Filed 2016·Application pending·0 cites
- 1455US2017115294A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Application pending·0 cites
- 1554US7785821B2Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2009·Granted Aug 31, 2010·0 cites·6 claims
- 1653US2013288267A1Detection of a polypeptide dimer by a bivalent binding agentROCHE DIAGNOSTICS OPERATIONS·Filed 2013·Application pending·0 cites
- 1752US2013288266A1Detection of a posttranslationally modified polypeptide by a bi-valent binding agentGERG MICHAEL·Filed 2013·Application pending·0 cites
- 1850US2009286328A1Use of protein s100a12 as a marker for colorectal cancerWILD NORBERT·Filed 2008·Application pending·0 cites
- 1950US2012157335A1Flap Endonuclease-1 As A Marker For CancerWILD NORBERT·Filed 2012·Application pending·0 cites
- 2050US2013344094A1Polypeptide-polynucleotide-complex and its use in targeted effector moiety deliveryHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2149US2017275380A1Detection of a polypeptide dimer by a bivalent binding agentROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Application pending·0 cites
- 2245US9637774B2Glycosylated modified flavin adenine dinucleotide-dependent glucose dehydrogenases, compositions thereof as well as methods of making and using the sameROCHE DIABETES CARE INC·Filed 2014·Granted May 2, 2017·0 cites·18 claims
- 2345US2023221316A1Use of automated platforms for preparation of biomarker and romanowsky-type stained sample printed on a slideROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 2444US2011097756A1Apex as a marker for lung cancerHAGMANN MARIE-LUISE·Filed 2009·Application pending·0 cites
- 2543US8951738B2CYBP as a marker for lung cancerANDRES HERBERT·Filed 2011·Granted Feb 10, 2015·0 cites·14 claims
- 2643US2009075312A1Assessing colorectal cancer by measuring osteopontin and carcinoembryonic antigenWILD NORBERT·Filed 2008·Application pending·0 cites
- 2742US8252542B2Serpin B 13 as a marker for squamous cell carcinoma of the lungROESSLER MARKUS·Filed 2011·Granted Aug 28, 2012·0 cites·31 claims
- 2841US2007184498A1Protein RS15A as a marker for colorectal cancerTACKE MICHAEL·Filed 2006·Application pending·0 cites
- 2940US2006194266A1Use of protein RLA-0 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3040US2006177880A1Use of PRN3/ILEU as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3140US2006188949A1Use of protein PLST as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3240US2006188950A1Use of protein spee as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3340US2006199232A1Use of protein PSE3 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3440US2007218510A1Use of protein PSA3 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2006·Application pending·0 cites
- 3539US10175241B2ASC as a marker for lung cancerANDRES HERBERT·Filed 2010·Granted Jan 8, 2019·0 cites·13 claims
- 3639US2011212464A1Pacap as a marker for cancerHAGMANN MARIE-LUISE·Filed 2011·Application pending·0 cites
- 3738US2006121540A1Use of protein MASP as a marker for colorectal cancerTACKE MICHAEL·Filed 2005·Application pending·0 cites
- 3838US2007161062A1Protein CBP2 as a marker for colorectal cancerTACKE MICHAEL·Filed 2006·Application pending·0 cites
- 3937US9926536B2Glucose oxidase variants and methods of using the sameROCHE DIABETES CARE INC·Filed 2015·Granted Mar 27, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Michael Tacke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →